AEGiS-SAPA: ARV programme could be enlarged South African Press AssociationImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


ARV programme could be enlarged

South African Press Association - October 30, 2009


-- The health ministry is doing cost studies on extending its antiretroviral therapy programme to HIV carriers with a higher CD4 count, deputy director general Kamy Chetty said.

Chetty confirmed to Sapa that this was possibly linked to a policy announcement President Jacob Zuma has said Health Minister Aaron Motsoaledi would make next week.

At the moment, the state provides medication to HIV sufferers once their CD4 count - the number of lymphocytes per cubic millimetre of blood - drops below 200.

This is in line with early World Health Organisation guidelines for poorer nations. The recommendations have been revised because of the benefits of starting therapy before immune suppression reaches that level.

Chetty told Parliament's health portfolio committee that the department was studying the cost implications of extending the treatment programme to patients whose CD4 counts are below 300.

"Giving ARTs [antiretroviral therapy] to people with a CD4 count of 150 costs a lot less than giving it to people with a CD4 count of 300... These exercises are being done right now," she said.

"If the policy changes the (expenditure) estimates will go up," she told the committee.

She said the health department was determined to intensify its programme to prevent mother-to-child transmission and was also doing cost studies in this regard.

"The government and the department would like to see a situation where no child is born with HIV."

The Treatment Action Campaign has called for the programme to be extended, citing the example of neighbouring Botswana where the drugs are given to HIV carriers by the state once their CD4 count hits 350.

Zuma this week said South Africa must step up the fight against HIV/Aids and called for a behaviour change among the population to stem the tide of infection.

He said high levels of awareness of the disease and the world's biggest antiretroviral (ARV) campaign were not sufficient to stop the pandemic.

"We should now seriously work to convert that knowledge into a change of behaviour."

Zuma said the SA National Aids Council, under Deputy President Kgalema Motlanthe's leadership, would develop a set of measures to strengthen the programmes already in place.

The Democratic Alliance on Friday called for the roll-out of ARV medication to be increased.

It welcomed Zuma's appeal to make fighting Aids a top priority but questioned whether the state had the ability to put this into action.

DA spokesman Mike Waters pointed out that Motsoaledi had to concede earlier this year that South Africa would not meet its target of providing ARVs to 80 percent of people living with HIV/Aids by 2011 because of logistical problems and a lack of personnel.

"In other words, as is increasingly becoming the case with Jacob Zuma's administration, a very public and critically important undertaking on behalf of the government proved to be misguided and poorly thought through, with the consequence that it had to be downscaled."


091030
SA091003


Copyright © 2009 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .